Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·Can caregivers stick with a self-administered hypnosis program?
Clinical TrialA 2021 registry describes proposed randomized feasibility research comparing self-administered hypnosis with sham white noise hypnosis and planned caregiver sleep measures.
-
Evidence date ·A pilot asks whether clearing senescent cells could improve walking after childhood cancer
Clinical TrialA 2021 registry pilot pairs two short treatments intended to clear senescent cells with walking-speed and blood-marker checks at days 60 and 150.
-
Evidence date ·Aging immunity may need new cells and healthy support tissues
Review or Meta-AnalysisAn August 2025 review links declining T-cell renewal to thymus and lymph-node changes and asks how treatment findings translate to ordinary aging.
-
Evidence date ·How aging biology may shape physical and cognitive function after cancer
Review or Meta-AnalysisA 2021 review connects aging biology, nutrition, and functional measures to cancer survivorship research—without promising a ready treatment.
-
Evidence date ·Four weeks of supplementation revealed different brain creatine responses
Clinical TrialIn 19 healthy men given guanidinoacetic acid for four weeks, brain creatine rose in some locations and fell in another. No functional benefit was established.
-
Evidence date ·How aging changes the heart’s blood supply and complicates treatment choices
Review or Meta-AnalysisA 2026 review connects heart aging to vessel stiffening, cellular stress and repair tradeoffs while separating clinical studies from proven patient benefit.
-
Evidence date ·Could targeting aging cells protect the Parkinson’s brain?
Review or Meta-AnalysisA 2026 review traces how aging immune cells may worsen Parkinson’s inflammation and compares clearing senescent cells with quieting their signals.
-
Evidence date ·What happens when researchers remove cells that stop dividing in diseased lung arteries
Review or Meta-AnalysisA review compares opposing animal results in pulmonary hypertension, showing why timing remains a hypothesis and how changing cell signals differs from removing cells.
-
Evidence date ·How immune cells can both age tissues and clear cells that stop dividing
Review or Meta-AnalysisA 2025 review connects immune aging with senescent-cell buildup and compares human tissue findings with animal results from drugs and engineered T cells.
-
Evidence date ·How drug research is targeting different routes in immune aging after COVID
Review or Meta-AnalysisA December 2024 review compares drug targets in acute COVID, brain-inflammation models and other diseases, while patient benefit remains uncertain.